Rock Springs Capital - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $95,916.91 -0.47%
Ethereum $3,472.62 +4.51%
BNB $647.30 -0.37%
Optimism $2.31 +9.82%
Arbitrum $0.92 +11.95%
Solana $242.14 -2.03%
Polygon $0.58 +7.58%
Cosmos $8.22 -0.74%
Avalanche $42.92 +8.22%

Bitcoin $95,916.91 -0.47%
Ethereum $3,472.62 +4.51%
BNB $647.30 -0.37%
Optimism $2.31 +9.82%
Arbitrum $0.92 +11.95%
Solana $242.14 -2.03%
Polygon $0.58 +7.58%
Cosmos $8.22 -0.74%
Avalanche $42.92 +8.22%

Rock Springs Capital

company

Investments

Number of Investments

Number of Lead Investments

17

0

Rock Springs Capital has made 17 investments. Their most recent investment was on Oct 11, 2022, when Treeline Biosciences, Inc raised

Date	Company Name	Round	Money Raised	Industry	Lead Investor
Oct 11, 2022	Treeline Biosciences	Series A	—	Biotechnology	—
Jul 18, 2022	Immunocore	Post-IPO Equity	—	Biotechnology	—
Dec 7, 2021	Freenome	Series D	—	Biotechnology	—
Jun 25, 2021	Kindbody	Series C	—	Employee Benefits	—
May 11, 2021	Caris Life Sciences	Private Equity（PE）	—	Biotechnology	—
Mar 22, 2021	Aura Biosciences	Series Unknown	—	Biotechnology	—
Jan 19, 2021	Verve Therapeutics	Series B	—	Biotechnology	—
Aug 26, 2020	Freenome	Series C	—	Biotechnology	—
Jul 8, 2020	Kindbody	Series B	—	Employee Benefits	—
Mar 2, 2020	Immunocore	Series B	—	Biotechnology	—
May 16, 2017	Synlogic	Series C	—	Biotechnology	—
Jul 18, 2016	Ardelyx	Post-IPO Equity	—	Biotechnology	—
Jun 22, 2015	Ardelyx	Post-IPO Equity	—	Biotechnology	—
May 12, 2015	BeiGene	Series B	—	Biotechnology	—
May 7, 2015	Adaptive Biotechnologies	Series F	—	Biotechnology	—
Apr 30, 2015	Mirna Therapeutics	Series D	—	Biotechnology	—
Oct 13, 2014	Invitae	Series F	—	Biotechnology	—